Physician profile
Mark L Fruiterman
NPI 1609879709
$1,157.59
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $938 · 2020: $187 · 2022: $13.21 · 2024: $19.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $232.35 | 2019 | |
| Novo Nordisk INC | $208.60 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $131.61 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $113.48 | 2019-2022 | |
| Abbott Laboratories | $66.32 | 2019 | |
| Corcept Therapeutics | $66.03 | 2019-2020 | |
| Abbvie INC. | $50.81 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $46.29 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $42.92 | 2019 | |
| Amgen INC. | $39.40 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $31.57 | 2019 | |
| Dexcom, INC. | $30.17 | 2019-2020 | |
| Mannkind Corporation | $25.49 | 2019-2020 | |
| Rgh Enterprises LLC | $19.34 | 2024 | |
| Lifescan, INC. | $16.45 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $12.91 | 2019 | |
| Lilly USA, LLC | $11.97 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.88 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Fruiterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.